正在加载视频...
视频加载失败
How does endocrinology support integrated management of metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH) in obesity and type 2 diabetes? Insights from Prof. Krag & Prof. Mingrone.
0 条评论
暂无评论
原始帖子的评论将显示在这里

